|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Blauvelt, Andrew; Wollenberg, Andreas; Eichenfield, Lawrence F.; Zhang, Haixin; Sierka, Debra; Khokhar, Faisal A.; Vakil, Jignesh; Shabbir, Arsalan; Marco, Ainara Rodriguez und Cyr, Sonya L.
(2022):
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab.
In: Advances in Therapy, Bd. 40, Nr. 1: S. 367-380
Blauvelt, Andrew; Langley, Richard G.; Lacour, Jean-Philippe; Toth, Darryl; Laquer, Vivian; Beissert, Stefan; Wollenberg, Andreas; Herranz, Pedro; Pink, Andrew E.; Peris, Ketty; Fangel, Stine; Gjerum, Le; Corriveau, Joshua; Saeki, Hidehisa; Warren, Richard B.; Simpson, Eric und Reich, Kristian
(2022):
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.
In: Journal of the American Academy of Dermatology, Bd. 87, Nr. 4: S. 815-824
Paller, Amy S.; Beck, Lisa A.; Blauvelt, Andrew; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Chen, Zhen; Khokhar, Faisal A.; Vakil, Jignesh; Zhang, Annie; Bansal, Ashish und Cyr, Sonya L.
(2022):
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
In: Pediatric Dermatology, Bd. 39, Nr. 2: S. 187-196
Gottlieb, Alice B.; Blauvelt, Andrew; Prinz, Jörg C.; Papanastasiou, Philemon; Pathan, Rashidkhan; Nyirady, Judit; Fox, Todd und Papavassilis, Charis
(2016):
Secukinumab Self-Administration by Prefilled Syringe Maintains. Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial.
In: Journal of Drugs in Dermatology, Bd. 15, Nr. 10: S. 1226-1234